Your browser doesn't support javascript.
loading
Plasmodium vivax Infections in Duffy-Negative Individuals in the Democratic Republic of the Congo.
Brazeau, Nicholas F; Whitesell, Amy N; Doctor, Stephanie M; Keeler, Corinna; Mwandagalirwa, Melchior Kashamuka; Tshefu, Antoinette K; Likwela, Joris L; Juliano, Jonathan J; Meshnick, Steven R.
Afiliação
  • Brazeau NF; Medical Scientist Training Program, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
  • Whitesell AN; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Doctor SM; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Keeler C; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.
  • Mwandagalirwa MK; Department of Geography, University of North Carolina, Chapel Hill, North Carolina.
  • Tshefu AK; Programme National de la Lutte Contre le Paludisme, Kinshasa, Democratic Republic of Congo.
  • Likwela JL; Programme National de la Lutte Contre le Paludisme, Kinshasa, Democratic Republic of Congo.
  • Juliano JJ; Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
  • Meshnick SR; Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
Am J Trop Med Hyg ; 99(5): 1128-1133, 2018 11.
Article em En | MEDLINE | ID: mdl-30203741
ABSTRACT
Although Plasmodium vivax has been assumed to be absent from sub-Saharan Africa because of the protective mutation conferring the Duffy-negative phenotype, recent evidence has suggested that P. vivax cases are prevalent in these regions. We selected 292 dried blood spots from children who participated in the 2013-2014 Demographic and Health Survey of the Democratic Republic of the Congo (DRC), to assess for P. vivax infection. Four P. vivax infections were identified by polymerase chain reaction, each in a geographically different survey cluster. Using these as index cases, we tested the remaining 73 samples from the four clusters. With this approach, 10 confirmed cases, three probable cases, and one possible case of P. vivax were identified. Among the 14 P. vivax cases, nine were coinfected with Plasmodium falciparum. All 14 individuals were confirmed to be Duffy-negative by sequencing for the single point mutation in the GATA motif that represses the expression of the Duffy antigen. This finding is consistent with a growing body of literature that suggests that P. vivax can infect Duffy-negative individuals in Africa. Future molecular and sequencing work is needed to understand the relationship of these isolates with other P. vivax samples from Asia and South America and discover variants linked to P. vivax virulence and erythrocyte invasion.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Vivax / Sistema do Grupo Sanguíneo Duffy Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male País como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Malária Vivax / Sistema do Grupo Sanguíneo Duffy Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male País como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article